Lucid Group
About:
Lucid aims to develop a unique 3 in one diagnostic device.
Website: http://www.lucidinnovation.com
Twitter/X: lucidinnovation
Top Investors: SBRI Healthcare
Description:
Lucid aims to develop a unique 3 in one diagnostic device. The device would help intuitive, fast and economic measure biophysiological markers (pressure, sensation and muscle contractility – via EMG), enabling more precise diagnosis of the functional deficits in faecal incontinence at primary care.
Total Funding Amount:
917000 GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Manchester, Manchester, United Kingdom
Founded Date:
2002-01-01
Contact Email:
ideas(AT)lucidinnovation.com
Founders:
Alistair Williamson
Number of Employees:
11-50
Last Funding Date:
2015-02-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai